Shiver; John W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shiver; John W..The latest application filed is for "peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease".

Company Profile

0.10.33

Shiver; John W. - Chalfont PA
SHIVER; JOHN W. - DOYLESTOWN PA
Shiver, John W - Chalfont PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Hepatitis C virus vaccine Grant 8,142,794 - Emini , et al. March 27, 2	2012-03-27
Peptide Conjugate Compositions And Methods For The Prevention And Treatment Of Alzheimer's Disease App 20110052611 - GARSKY; VICTOR M. ; et al.	2011-03-03
Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease Grant 7,850,973 - Garsky , et al. December 14, 2	2010-12-14
Broadly Representative Antigen Sequences and Method for Selection App 20100183651 - Finnefrock; Adam C. ; et al.	2010-07-22
Human antibodies interacting with HIV gp41 Grant 7,744,887 - Shiver , et al. June 29, 2	2010-06-29
Hepatitis C virus vaccine Grant 7,598,362 - Emini , et al. October 6, 2	2009-10-06
Hepatitis C Virus Vaccine App 20090233992 - Emini; Emilio A. ; et al.	2009-09-17
Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease App 20090098155 - Garsky; Victor M. ; et al.	2009-04-16
Adenovirus Serotype 26 Vectors, Nucleic Acid and Viruses Produced Thereby App 20080254059 - Bett; Andrew J. ; et al.	2008-10-16
Adenoviral Vector Compositions App 20080063656 - Emini; Emilio A. ; et al.	2008-03-13
Human Antibodies Interacting with Hiv Gp41 App 20070248613 - Shiver; John W. ; et al.	2007-10-25
Enhanced first generation adenovirus vaccines expressing condon optimized HIV1-Gag, Pol, Nef and modifications App 20070077257 - Emini; Emilio A. ; et al.	2007-04-05
Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modifications App 20070054395 - Emini; Emilio A. ; et al.	2007-03-08
Therapeutic immunization of hiv-infected individuals App 20060216272 - Emini; Emilio A. ; et al.	2006-09-28
Polynucleotide vaccines expressing codon optimized HIV-1 Pol and modified HIV-1 Pol App 20060148750 - Shiver; John W. ; et al.	2006-07-06
Coordinate in vivo gene expression Grant 6,995,008 - Liu , et al. February 7, 2	2006-02-07
Coordinate in vivo gene expression App 20060018881 - Liu; Margaret A. ; et al.	2006-01-26
Polynucleotide vaccines expressing codon optimized HIV-1 Nef and modified HIV-1 Nef App 20050215508 - Shiver, John W. ; et al.	2005-09-29
Method of inducing an enhanced immune response against hiv App 20050106123 - Emini, Emilio A ; et al.	2005-05-19
Synthetic hepatitis C genes App 20050074752 - Donnelly, John J. ; et al.	2005-04-07
Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modifications App 20050070017 - Emini, Emilio A. ; et al.	2005-03-31
Hepatitis c virus vaccine App 20040247615 - Emini, Emilio A ; et al.	2004-12-09
Influenza virus vaccine App 20040223976 - Bianchi, Elisabetta ; et al.	2004-11-11
Adenovirus serotype 34 vectors, nucleic acids and virus produced thereby App 20040191222 - Emini, Emilio A. ; et al.	2004-09-30
Adenovirus serotype 24 vectors, nucleic acids and virus produced thereby App 20040185555 - Emini, Emilio A. ; et al.	2004-09-23
Synthetic HIV gag genes App 20040180329 - Shiver, John W. ; et al.	2004-09-16
Adenovirus carrying gag gene HIV vaccine Grant 6,787,351 - Chen , et al. September 7, 2	2004-09-07
Methods for propagating adenovirus and virus produced thereby App 20040106194 - Bett, Andrew J. ; et al.	2004-06-03
Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol.nef and modifications App 20040101957 - Emini, Emilio A. ; et al.	2004-05-27
Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-gag, pol, nef and modifications Grant 6,733,993 - Emini , et al. May 11, 2	2004-05-11
Nucleic acid pharmaceuticals-influenza matrix App 20040087521 - Donnelly, John J. ; et al.	2004-05-06
Polynucleotide vaccines expressing codon optimized hiv-1 pol and modified hiv-1 pol App 20040063653 - Shiver, John W. ; et al.	2004-04-01
Synthetic HIV gag genes Grant 6,696,291 - Shiver , et al. February 24, 2	2004-02-24
Vaccines comprising synthetic genes App 20030229214 - Shiver, John W. ; et al.	2003-12-11
Adenovirus carrying gag gene HIV vaccine App 20030228329 - Chen, Ling ; et al.	2003-12-11
Synthetic hepatitis C genes Grant 6,653,125 - Donnelly , et al. November 25, 2	2003-11-25
Polynucleotide vaccines expressing codon optimized hiv-1 nef and modified hiv-1 nef App 20030096778 - Shiver, John W ; et al.	2003-05-22
Synthetic HIV genes App 20030087225 - Shiver, John W. ; et al.	2003-05-08
Synthetic Hepatitis C Genes App 20030053987 - DONNELLY, JOHN J. ; et al.	2003-03-20
Vaccines comprising synthetic genes Grant 6,534,312 - Shiver , et al. March 18, 2	2003-03-18
Synthetic HIV gag genes App 20030050468 - Shiver, John W. ; et al.	2003-03-13
Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modifications App 20030044421 - Emini, Emilio A. ; et al.	2003-03-06
Adenovirus carrying gag gene HIV vaccine App 20020061517 - Chen, Ling ; et al.	2002-05-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.